Pharma Stock Roundup: ABBV’s Deal With RGNX, LLY COVID Drug’s Government Order Win

Posted byKinjel Shah Leave a comment on Pharma Stock Roundup: ABBV’s Deal With RGNX, LLY COVID Drug’s Government Order Win

AbbVie (ABBV) buys rights to Regenexbio’s gene therapy candidate for chronic retinal diseases. Lilly (LLY) will supply additional doses of its COVID-1…

Leave a comment

Your email address will not be published. Required fields are marked *